A detailed history of Pictet Asset Management Holding Sa transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 10,542 shares of TXG stock, worth $238,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,542
Previous 10,848 2.82%
Holding current value
$238,987
Previous $407,000 49.63%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$19.45 - $37.37 $5,951 - $11,435
-306 Reduced 2.82%
10,542 $205,000
Q1 2024

May 14, 2024

BUY
$36.08 - $54.3 $11,040 - $16,615
306 Added 2.9%
10,848 $407,000
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $430,746 - $663,935
10,542 New
10,542 $434,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.15B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.